MFA-021

N/A

Report date: 2025/01/08 15:16:23

Base Information

Drug NameMFA-021
Drug Alias NameMFA021MFA-021
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti Glucocorticoid-induced tumor necrosis factor receptor-related proteinInterleukin-15 receptors agonists
TargetsGlucocorticoid-induced tumor necrosis factor receptor-related proteinInterleukin-15 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMediMabBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesMediMabBio Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A